Videos / New pneumococcal 15-valent conjugate vaccine that includes coverage against serotype 3
In this Product Explainer, Public Health Physician and Infectious Diseases Epidemiologist Prof Paul Van Buynder explains the burden of pneumococcal disease in both children and adult population. He explains why PCV 15 has increased serotype coverage and why improved immunogenicity against serotype 3 is important both from a clinical and public health perspective (5 mins).

Frozen Shoulder – A Practical Guide to Assessment and Management

Implementing the Four Pillars of Heart Failure Management in GP

PCOS Update

Biologics in COPD – 20% of Your Patients Could Benefit

expert
Public Health Physician and Infectious Diseases Epidemiologist; Professor, School of Medicine, Griffith University, Queensland